首页> 美国卫生研究院文献>Pharmaceutics >Bioavailability Enhancement of Poorly Water-Soluble Drugs via Nanocomposites: Formulation–Processing Aspects and Challenges
【2h】

Bioavailability Enhancement of Poorly Water-Soluble Drugs via Nanocomposites: Formulation–Processing Aspects and Challenges

机译:通过纳米复合材料提高水溶性差的药物的生物利用度:制剂-加工方面和挑战

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Drug nanoparticles embedded in a dispersant matrix as a secondary phase, i.e., drug-laden nanocomposites, offer a versatile delivery platform for enhancing the dissolution rate and bioavailability of poorly water-soluble drugs. Drug nanoparticles are prepared by top-down, bottom-up, or combinative approaches in the form of nanosuspensions, which are subsequently dried to prepare drug-laden nanocomposites. In this comprehensive review paper, the term “nanocomposites” is used in a broad context to cover drug nanoparticle-laden intermediate products in the form of powders, cakes, and extrudates, which can be incorporated into final oral solid dosages via standard pharmaceutical unit operations, as well as drug nanoparticle-laden strip films. The objective of this paper is to review studies from 2012–2017 in the field of drug-laden nanocomposites. After a brief overview of the various approaches used for preparing drug nanoparticles, the review covers drying processes and dispersant formulations used for the production of drug-laden nanocomposites, as well as various characterization methods including quiescent and agitated redispersion tests. Traditional dispersants such as soluble polymers, surfactants, other water-soluble dispersants, and water-insoluble dispersants, as well as novel dispersants such as wet-milled superdisintegrants, are covered. They exhibit various functionalities such as drug nanoparticle stabilization, mitigation of aggregation, formation of nanocomposite matrix–film, wettability enhancement, and matrix erosion/disintegration. Major challenges such as nanoparticle aggregation and poor redispersibility that cause inferior dissolution performance of the drug-laden nanocomposites are highlighted. Literature data are analyzed in terms of usage frequency of various drying processes and dispersant classes. We provide some engineering considerations in comparing drying processes, which could account for some of the diverging trends in academia vs. industrial practice. Overall, this review provides rationale and guidance for drying process selection and robust nanocomposite formulation development, with insights into the roles of various classes of dispersants.
机译:嵌入作为第二相的分散剂基质中的药物纳米颗粒,即载有药物的纳米复合材料,为提高水溶性差的药物的溶出速率和生物利用度提供了多功能的递送平台。通过自上而下,自下而上或组合的方法以纳米悬浮液的形式制备药物纳米颗粒,随后将其干燥以制备载有药物的纳米复合材料。在这份全面的综述文件中,“纳米复合材料”一词在广义上涵盖了粉末,蛋糕和挤出物形式的载有药物纳米颗粒的中间产品,可以通过标准药物单位操作将其掺入最终的口服固体剂型中。以及载有药物纳米颗粒的条状薄膜。本文的目的是回顾2012-2017年载药纳米复合材料领域的研究。在简要概述了用于制备药物纳米颗粒的各种方法后,该综述涵盖了用于生产载药纳米复合材料的干燥工艺和分散剂配方,以及包括静态和搅拌性再分散测试在内的各种表征方法。涵盖了传统的分散剂,例如可溶性聚合物,表面活性剂,其他水溶性分散剂和水不溶性分散剂,以及新型的分散剂,例如湿磨超崩解剂。它们具有多种功能,例如药物纳米颗粒稳定,减轻聚集,形成纳米复合基质-膜,提高润湿性和基质侵蚀/崩解。突出了主要挑战,例如纳米颗粒聚集和可再分散性差,导致载药纳米复合材料的溶解性能较差。根据各种干燥过程和分散剂类别的使用频率分析文献数据。在比较干燥过程时,我们提供了一些工程方面的考虑,这可以解释学术界与工业实践之间的某些差异趋势。总体而言,本综述为干燥工艺选择和强大的纳米复合材料配方开发提供了理论依据和指导,并深入了解了各种分散剂的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号